INVA Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
106.1M
-11.3%
119.6M
+22.0%
98.0M
-14.5%
114.6M
+6.3%
107.8M
Cost of Revenue
21.7M
-2.7%
22.3M
+0.8%
22.2M
-43.1%
38.9M
+20.7%
32.3M
Gross Profit
84.4M
-13.2%
97.2M
+28.2%
75.8M
+0.2%
75.7M
+0.2%
75.5M
Operating Expenses
42.2M
-9.0%
46.4M
+23.1%
37.7M
+2.7%
36.7M
-10.5%
41.0M
R&D
5.2M
+0.5%
5.2M
-1.0%
5.2M
+15.1%
4.6M
-66.7%
13.7M
SG&A
37.0M
+7.1%
34.6M
+6.6%
32.4M
+1.0%
32.1M
+17.7%
27.3M
Operating Income
42.2M
-17.1%
50.9M
+33.3%
38.2M
-2.1%
39.0M
+12.8%
34.6M
EBITDA
65.6M
+37.1%
47.8M
-0.8%
48.2M
-1.9%
49.1M
-14.9%
57.7M
Net Income
-73888000
+11.4%
-83420000
-144.7%
186.6M
+13.7%
164.2M
+82.6%
89.9M
EPS (Basic)
$-1.03
+9.6%
$-1.14
-145.2%
$2.52
+15.1%
$2.19
+68.5%
$1.30
EPS (Diluted)
$-1.03
+9.6%
$-1.14
-151.4%
$2.22
+44.2%
$1.54
+42.6%
$1.08
Shares (Diluted)
72.1M
-1.8%
73.4M
-13.5%
84.8M
-20.6%
106.9M
+25.8%
85.0M
Innoviva (INVA) — Financials